Durvalumab improves survival of non-small cell lung cancer patients
Moffitt researchers conducted a Phase III trial which found durvalumab to increase the survival of patients with non-small cell lung cancer...
List view / Grid view
News
Poor diabetes control leads to increased serious infections
Poor diabetes control leads to an increase in serious infections such as pneumonia, and could mean an increased risk of death...
CPD-certified conference programme for Lab Innovations 2018
Two days of free science focused presentations...
The essential guide to greener and more sustainable laboratories
Visit Lab Innovations (NEC, 31 October - 1 November) to find out everything you need to know about making your lab more sustainable...
NIAID plan for in-depth tuberculosis research
NIAID has released a plan for research in the infectious disease TB in order to strengthen efforts and resolve to attack this disease...
Pharma firms step up plans to beat Brexit supply chain disruption
The EMA has revised downwards the number of medicines expected to face Brexit-related supply disruptions from 108, earlier this year, to a current level of 39...
Pioneering radiotherapy machine treats its first patient in the UK
Improved accuracy and fewer patient side effects are among the benefits claimed for the pioneering radiotherapy machine...
Holistic approach to data management for pharmaceutical manufacturers
PharmaIntegrity makes it quick and easy to identify and trend cleanroom contamination problems before they occur...
Inhaler delivers cannabinoids faster at lower doses
Researchers have released data on a clinical trial using specific inhalers and oral capsules to deliver cannabinoids to participants...
Vaccine facility targets development and manufacturing to fight pandemics
The new hub is designed to speed the response to deadly pandemics by improving the development and manufacturing of vaccines – particularly in low- and middle-income countries...
Biosimilars market to increase to $61.47 billion
A report has suggested that the biosimilars market growth will increase at a CAGR of 34.2 percent over the course of the period analysed...
CPhI Worldwide announces finalists of the largest ever pharma awards
Record entries highlight a big year of innovation in pharma...
Thermo Fisher Scientific to launch global customer solution centres
Supporting scientists through the collaborative development of next generation chromatography and mass spectrometry solutions in Pharma/Biopharma and Food/Beverage Industries...
Cell therapy rejected for aggressive adult lymphoma on the NHS
A CAR-T immunotherapy for adults with an aggressive form of non-Hodgkin lymphoma has been provisionally rejected by the NHS...
Discover Roquette’s latest biopharmaceutical innovations and our 360° digital experience
Learn how Roquette supports customers in the development of innovative pharmaceutical formulations and new biopharma solutions...
